PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Eur Neuropsychopharmacol. Author manuscript; available in PMC Sep 1, 2010.
Published in final edited form as:
PMCID: PMC2716397
NIHMSID: NIHMS106609
Gene expression is altered in hippocampus following prenatal viral infection in mouse at E16
S. Hossein Fatemi,abc Timothy D. Folsom,a Teri J. Reutiman,a Hao Huang,d Kenichi Oishi,d and Susumu Morid
aDepartment of Psychiatry, Division of Neuroscience Research, University of Minnesota School of Medicine, Minneapolis, USA
bDepartment of Pharmacology, University of Minnesota School of Medicine, Minneapolis, USA
cDepartment of Neuroscience, University of Minnesota School of Medicine, Minneapolis, USA
dDepartment of Radiology, Division of NMR, Johns Hopkins University School of Medicine, Baltimore, USA
Address for correspondence: S.H. Fatemi, M.D., Ph.D., Department of Psychiatry, Division of Neuroscience Research, University of Minnesota, Medical School, MMC 392, 420 Delaware St. S.E., Minneapolis, MN 55455, Tel: 612-626-3633, Fax: 612-624-8935, Email: fatem002/at/umn.edu
The hippocampus governs memory formation and emotional regulation and there is widespread evidence of hippocampal dysfunction in psychiatric disorders including schizophrenia and autism. There is abundant evidence that prenatal viral infection may play a role in the development of these two disorders. In the current study we have examined gene expression and structural changes of the hippocampi of exposed neonates following maternal infection at E16 (middle second trimester). We observed significant changes in gene expression at P0 (birth), P14 (childhood), and P56 (adulthood) including a number of candidate genes for autism and schizophrenia. qRT-PCR, verified the direction and magnitude of change for 5 of the genes from the microarray data set revealed mRNA changes for additional genes associated with schizophrenia and autism. MRI revealed a decrease in hippocampal volume at P35 (adolescence). Our results demonstrate altered gene expression and reduced hippocampal volume following prenatal viral infection at E16.
Keywords: schizophrenia, autism, viral model, mouse, DNA microarray, hippocampus
The hippocampus governs memory formation and emotional regulation and there is widespread evidence of hippocampal dysfunction in psychiatric disorders including schizophrenia and autism. Hippocampal abnormalities in subjects with schizophrenia include disturbed cytoarchitecture, biochemical changes, and an overall reduction in volume (Arnold and Trojanowski, 1996; Harrison and Owen, 2003; Weiss et al., 2005). A greater prevalence of hippocampal shape anomaly (HAS), characterized by a rounded shape, medial location, and a deep collateral sulcus, has been found in familial schizophrenia patients (Connor et al., 2004). Likewise, abnormalities in hippocampus have been observed in subjects with autism including a reduction in neuronal cell size and increased cell density (Bauman and Kemper 1994). MRI volumetric studies have found alterations in hippocampal volume, with Aylward et al. (1999) and Herbert et al. (2003) finding a reduction in volume for adults and children, respectively, while, in contrast, Sparks et al. (2002) found an increase in volume in autistic children.
There is robust epidemiologic evidence indicating that environmental contributions, including prenatal infections, may lead to genesis of schizophrenia (Fatemi, 2005, 2008; Brown, 2004, 2006) and autism (Arndt et al., 2006; Libbey et al., 2005). Animal models, developed by our laboratory and others, have demonstrated that viral infections and/or immune challenges during pregnancy lead to abnormal brain structure and function in the exposed offspring that replicate abnormalities observed in brains of subjects with schizophrenia and autism (Fatemi et al., 2005, 2008a; Meyer et al, 2006, 2007; Shi et al., 2003).
Our laboratory has previously described abnormal changes following infection at E9, which corresponds to middle first trimester (Fatemi et al., 2005; Shi et al., 2003), and E18, which corresponds to late second trimester (Fatemi et al., 2008a). Embryonic day 16 (E16) in mice corresponds to middle second trimester in humans, a period when prenatal infection has been linked to the development of schizophrenia later in life (reviewed in Brown et al., 2004; Susser et al., 1997). Additionally, E16 immediately follows the period of neurogenesis of hippocampal pyramidal cells (E11-E15.5; Rodier, 1980).
We hypothesized that middle second trimester infection (E16) in mice would alter brain gene expression in hippocampus including candidate genes for autism and schizophrenia. Moreover, we hypothesized that prenatal viral infection at E16 would reduce hippocampal volume in exposed offspring. Here, we present genetic and MRI data showing that a similar sublethal dose of human influenza virus (H1N1) in C57BL6J mice at E16, leads to altered expression of many brain genes in the hippocampi of the exposed mouse offspring.
2.1. Viral infection
All experimental protocols used in this study were approved by the Institute for Animal Care and Use and Institutional Biosafety Committees at the University of Minnesota. Influenza A/NWS/33 (H1N1) virus was obtained from R.W. Cochran, University of Michigan (Ann Arbor). A virus pool was prepared in Maden Darby canine kidney (MDCK) cells; the virus was ampuled and frozen at -80°C until used. Data were expressed as log10 cell culture infectious doses (CCID50)/ml by the method of Reed and Muench (Reed and Muench, 1938). By this titration, it was determined that at a dilution of 10-4.5, none of the mice died of the infection but displayed a mean lung consolidation scores and mean lung weights similar to those obtained by Fatemi et al (2002b) and had a mean virus titer of 105.25 CCID50/ml, indicating that a moderate but sublethal infection had been induced. This was the virus dose selected for use in the pregnant mouse study. On day 16 of pregnancy, C57BL6J mice (Charles River, Wilmington, MA) were anesthetized using 200 μl isoflurane, and intranasally (i.n.) administered a dilution of 10-4.5 of 6.5 log 10 (CCID50) per 0.1 ml human influenza virus A/NWS/33 in 90 μl of minimum essential medium (MEM). Sham infected mothers were treated identically but administered i.n. 90 μl MEM. After being infected, their drinking water contained 0.006% oxytetracycline (Pfizer, New York, NY) to control possible bacterial infections. Pregnant mice were allowed to deliver pups. The day of delivery was considered day 0. Groups of infected and sham-infected neonates were deeply anesthetized and killed on P0, P14, P35 and P56. Offspring were weaned from mothers at P21, and males and females were caged separately in groups of 2-4 littermates.
2.2. Brain collection and dissection
Pregnant mice were allowed to deliver pups. Day of delivery was considered as postnatal day P0. Male litter mates from P0, 14, 35, and 56 were obtained. Groups of infected (N=10 litters) and sham-infected male neonates (N=10 litters) were deeply anesthetized. The choice of ten animals per group was based on earlier calculations that yield an average effect size of 1.45sd between infected and control animals. With alpha = 0.05, and a sample size of 10 per group, power is = 0.798. Brains were removed from skull cavities following perfusion with phosphate-buffered 4% paraformaldehyde (pH 7.4) with later immersion in the same fixative for 14 days at 4°C and used for all imaging studies. Alternatively, unfixed cryopreserved brains were snap-frozen by immersion in liquid nitrogen and stored at -85°C for all gene array studies. Whole hippocampus was dissected using the method of Zapala et al. (2005), provided in step-by-step diagrams in their online supporting Appendix 2.
2.3. Microarray
Tissues (N=3 control and N=3 infected for hippocampus at each of three time points (P0 (birth), P14 (childhood), P56 (adulthood)) were prepared and microarray performed as previously described (Fatemi et al., 2008a). (For a detailed protocol please see Supplemental Experimental Procedures).
2.4. qRT-PCR
Quantitative RT-PCR for selected genes from our microarray data set that had an association with autism or schizophrenia was performed as previously described (Fatemi et al., 2005b, 2008) using the TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA) and a GAPDH endogenous control assay. Single strand cDNA was synthesized from 0.02 to 2.0 μg of each total RNA sample using the High Capacity cDNA Synthesis Kit (Applied Biosystems) according to the manufacturer's instructions. Approximately 20 ng of each cDNA (9 μL) was mixed with 10 μL of TaqMan® Gene Expression 2X PCR Master Mix (Applied Biosystems, Roche), and 1 μL of each indicated TaqMan® Gene Expression Assay (Applied Biosystems) in 384-well plates and analyzed on the 7900HT Fast Real Time PCR system according to the manufacturer's instructions (Applied Biosystems). Primary analysis of the acquired signal data was performed in SDS 2.3 and RQ Manager 1.2 (Applied Biosystems). Outlier reactions were removed after Grubb's test identification and differential expression was calculated using the ΔΔCT method.
2.5. MRI and DTI scanning
2.5.1. Brain tissue acquisition for MR scanning
Brains from C57BL/6 male neonates born to infected and sham infected E16 mothers at P0, P14, P35 and P56 (N=4 infected, N=3 control, 1 male/litter per group) were perfusion fixed in 4% paraformaldehyde in PBS buffer (pH 7.4) and subjected to DTI and MR scanning in PBS at room temperature as previously described (Fatemi et al., 2008a; Mori et al., 2001). (For a detailed protocol please see Supplemental Experimental Procedures).
2.6. Statistical Analysis
All statistical analyses were performed using SPSS. Differences of the normalized mRNA expression levels of selected genes between infected and control mice were assayed using two-tailed student's t-test. Significant differences are defined as those with at least a 1.5 fold change and a p value < 0.05.
We used Affymetrix microarrays, qRT-PCR, and MRI-based imaging to evaluate our results. Gene expression data showed a significant (p<0.05) at least 1.5 fold up- or downregulation of genes in hippocampus (299 upregulated and 191 downregulated at P0; 34 upregulated and 46 downregulated at P14; and 87 upregulated and 30 downregulated at P56) of mouse offspring (Supporting Table 1 online). Several genes, which have been previously implicated in etiopathology of autism and schizophrenia, were shown to be affected significantly (p<0.05) by DNA microarray including: Aquaporin 4 (Aqp4), Gamma-aminobutyric acid receptor gamma 1 (Gabrg1), forkhead box P2 (Foxp2), myelin basic protein (Mbp), neurotensin (Nts), and neural cell adhesion molecule (Nrcam) (Table 1). The direction and magnitude of change for Aqp4, Foxp2, Gabrg1, Mbp, and Nts were verified by qRT-PCR (Table 1).
Table 1
Table 1
Microarray and qRT-PCR Results for Selected Affected Genes in E16 Infected Mouse Hippocampus
Additionally, qRT-PCR showed significant changes in mRNA for other schizophrenia and autism susceptibility genes including autism susceptibility candidate 2 (Auts2), regulator of G Protein 4 (Rgs4), protein phosphatase 1, regulatory subunit 1b (Ppp1r1b), and glial fibrillary associated protein (Gfap) (Table 2). Interestingly, a number of genes related to myelination displayed significant downregulation of mRNA at P0 including Mbp, Myelin and lymphocyte-associated protein (Mal), Myelin-associated glycoprotein (Mag), myelin-associated oligodendrocytic basic protein (Mobp), Myelin oligodendrocyte protein (Mog), Proteolipid protein (myelin) 1 (Plp1) (Tables 1 and and22).
Table 2
Table 2
qRT-PCR Results for Selected Affected Genes in E16 Infected Mouse Hippocampus
Morphometric analysis of brain following infection of C57BL/6 mice at E16 revealed an approximately 7% reduction in overall brain volume at P14 (p<0.019) (Table 3) and a 6% reduction in area for hippocampus at P35 (p<0.014) (Table 3). Fractional anisotropy revealed no significant changes in white matter in hippocampus although there was a nearly significant increase in white matter at P14 (p<0.057;Table 4).
Table 3
Table 3
Changes in hippocampus area following infection at E16
Table 4
Table 4
Changes in hippocampus white matter following infection at E16
Prenatal viral infection led to altered gene expression in hippocampus at P0, P14, and P56 including schizophrenia and autism candidate genes such as Aqp4, Mbp, Nts, Foxp2, Nrcam, and Gabrg1. qRT-PCR verified the direction and magnitude of change for all of the above genes except for Nrcam. Additionally, qRT-PCR revealed significant changes in a number of other genes including downregulation of myelination genes Mag, Mog, Mobp, Mal, and Plp1 at P0. Morphometric analysis showed a reduction in hippocampal volume at P35. Table 5 compares gene expression and morphological changes following infection at E9, E16, and E18.
Table 5
Table 5
Comparative Effects of Prenatal Viral Infection at E9, E16, and E18 on Gene Expression and Brain Morphology
Interestingly, Foxp2, Mbp and Aqp4 also display altered expression following infection at E9 (Table 5; Fatemi et al., 2005, 2008c). Additionally, we have observed an upregulation of Foxp2 protein in hippocampus at P14 and P56 following infection at E18 (Table 5; Fatemi et al., 2008a). Foxp2 is a putative transcription factor containing a polyglutamine tract and a forkhead DNA binding domain. Foxp2 is associated with language and speech deficits (Hurst et al., 1990) that are commonly observed with autism. Aqp4 is localized to astrocytes and ependymal cells in brain and is involved with water transport (Papadopoulos et al., 2002; Verkman et al., 2006). Aqp4 is also reduced in cerebella of subjects with autism (Fatemi et al., 2008b). Mbp comprises about 30% of the myelin membrane and is believed to be involved in myelin compaction (Chambers and Perrone-Bizzozero, 2004). Mbp immunoreactivity is reduced in hippocampi of female subjects with schizophrenia (Chambers and Perrone-Bizzozero, 2004). Moreover, shiverer mice, which lack Mbp, display delayed action potentials (Lehman and Harrison, 2002) suggesting a role for Mbp in synaptic transmission. The recurrence of these genes in our data sets at multiple time points and multiple brain regions suggest they may be key to the changes observed following prenatal viral infection.
We demonstrated a 6% reduction in hippocampal volume (p<0.014) at P35 following infection at E16, and have previously demonstrated a 14% reduction in hippocampal volume (p<0.00005) at P35 following infection at E18 (Fatemi et al., 2008), consistent with the observed reductions in subjects with schizophrenia and autism. We do not have microarray data for this time point following infection at E16 or E18 so it is difficult to determine what genetic factors may play a role in hippocampal atrophy at P35. It is likely, however, that genes related to myelination, growth factors, and synaptic plasticity would be involved. Future studies should include microarray at P35 following infection at these dates. While infection at E18 resulted in morphological changes at P35, infection at E16 resulted in a greater number of changes at various time points as well as a greater number of changes in gene expression (Table 5) and it is likely that the two linked.
In conclusion, we observed that infection at E16 led to gene expression changes in hippocampi of exposed offspring. There were some similarities in gene expression when compared with infection at E9 and E18 although the total number of genes altered was greater following infection at E16. Moreover, there were a greater number of morphological changes. The greater magnitude of changes at E16 suggests that infection during middle second trimester leads to more deleterious effects in the exposed offspring than during middle first or late second trimester, consistent with findings that infection during middle second trimester carries a greater risk for the development of schizophrenia and autism in humans. These changes are in many cases similar to what has been observed in neuropsychiatric disorders, specifically autism and schizophrenia. Due to a low N, replication of our work is needed to examine the impact of these hippocampal changes in the exposed offspring.
Supplementary Material
01
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005;23(23):189–199. [PubMed]
  • Arnold SE, Trojanowski JQ. Recent advanced in defining the neuropathology of schizophrenia. Acta Neuropath. 1996;92:217–231. [PubMed]
  • Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, Barta PE, Pearlson GD. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology. 1999;53:2145–2150. [PubMed]
  • Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL, editors. The Neurobiology of Autism. Johns Hopkins University Press; Baltimore, MD: 1994. pp. 19–145.
  • Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774–780. [PubMed]
  • Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006;32:200–202. [PMC free article] [PubMed]
  • Chambers JS, Perrone-Bizzozero NI. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res. 2004;29:2293–2302. [PubMed]
  • Connor SE, Ng V, McDonald C, Schulze K, Morgan K, Dazzan P, Murray RM. A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Neuroradiology. 2004;46:523–534. [PubMed]
  • Fatemi SH, Sidwell R, Akhter P, Sedgewick J, Thuras P, Bailey K, Kist D. Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice. Synapse. 1998a;29:84–88. [PubMed]
  • Fatemi SH, Sidwell R, Kist D, Akhter P, Meltzer HY, Bailey K, Thuras P, Sedgwick J. Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero. Brain Res. 1998b;800:1–9. [PubMed]
  • Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P, Shier A, Sheikh S, Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry. 1999;4(2):145–154. [PubMed]
  • Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, Earle JA, Thuras P. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry. 2002a;7:633–640. [PubMed]
  • Fatemi SH, Earle J, Kanodia R, Kist D, Patterson P, Shi L, Sidwell RW. Prenatal viral infection causes macrocephaly and pyramidal cell atrophy in the developing mice. Cell Mol Neurobiol. 2002b;22:25–33. [PubMed]
  • Fatemi SH, Araghi-Niknam M, Laurence JA, Stary JM, Sidwell RW, Lee S. Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero. Schizophr Res. 2004;69:121–123. [PubMed]
  • Fatemi SH, editor. Neuropsychiatric Disorders and Infection. Taylor & Francis; London: 2005.
  • Fatemi SH, Pearce DA, Brooks AI, Sidwell RW. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: A potential animal model for schizophrenia and autism. Synapse. 2005;57:91–99. [PubMed]
  • Fatemi SH. Schizophrenia. In: Fatemi SH, Clayton P, editors. The Medical Basis of Psychiatry. Third. Humana Press; New York: 2008. pp. 85–108.
  • Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res. 2008a;99:56–70. [PMC free article] [PubMed]
  • Fatemi SH, Folsom TD, Reutiman TJ, Lee S. Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse. 2008b;62:501–507. [PMC free article] [PubMed]
  • Fatemi SH, Folsom TD, Reutiman TJ, Sidwell RW. Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin. Schizophr Res. 2008c;98:163–177. [PMC free article] [PubMed]
  • Feldcamp LA, Souza RP, Romano-Silva M, Kennedy JL, Wong AH. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia. Schizophr Res. 2008;103:192–200. [PubMed]
  • Gong X, Jia M, Ruan Y, Shuang M, Liu J, Wu S, Guo Y, Yang J, Ling Y, Yang X, Zhang D. Association between the FOXP2 gene and autistic disorder in Chinese population. Am J Med Genet B Neuropsychiatr Genet. 2004;127:113–116. [PubMed]
  • Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 2001;98:4746–4751. [PubMed]
  • Hamid EH, Hyde TM, Egan MF, Wolf SS, Herman MM, Nemeroff CB, Kleinman JE. Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biol Psychiatry. 2002;51:795–800. [PubMed]
  • Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361:417–419. [PubMed]
  • Herbert MR, Ziegler DA, Deutsch CK, O'Brien LM, Lange N, Bakardjiev A, Hodgson J, Adrien KT, Steele S, Makris N, Kennedy D, Harris GJ, Caviness VS., Jr Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain. 2003;126:1182–1192. [PubMed]
  • Hurst JA, Baraitser M, Auger E, Graham F, Norel SV. An extended family with a dominantly inherited speech disorder. Dev Med Child Neurol. 1990;32:352–355. [PubMed]
  • Kakinuma H, Ozaki M, Sato H, Takahashi H. Variation in GABA-A subunit gene copy number in an autistic patient with mosaic 4p duplication (p12p16) Am J Med Genet B Neuropsychiatr Genet. 2008;147B:973–975. [PubMed]
  • Laurence JA, Fatemi SH. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum. 2005;4:206–210. [PubMed]
  • Lehman DM, Harrison JM. Flash visual evoked potentials in the hypomyelinated mutant mouse shiverer. Doc Ophthalmol. 2002;104:83–95. [PubMed]
  • Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, Edenberg HJ, Kuczenski R, Geyer MA, Nurnberger JI, Jr, Faraone SV, Tsuang MT, Niculescu AB. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:129–158. [PubMed]
  • Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. Genome scan meta- analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73:34–48. [PubMed]
  • Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol. 2005;11:1–10. [PubMed]
  • Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, Nanba E, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N. Association of the neuronal cell adhesion molecule (NRCAM) gene variants with autism. Int J Neuropsychopharmacol. 2008;30:1–10. [PubMed]
  • Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci. 2006;26:4752–4762. [PubMed]
  • Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist. 2007;13:241–256. [PubMed]
  • Mori S, Ito R, Zhang J, Kaufmann WE, van Zijl PC, Solaiyappan M, Yarowsky P. Diffusion tensor imaging of the developing mouse brain. Magn Reson Med. 2001;46:18–23. [PubMed]
  • Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004;18:1291–1293. [PubMed]
  • Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 1938;27:493–497.
  • Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Perez-Tur J, Najera C, Molto MD, de Frutos R. Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations, Psychiatr. Genet. 2006;16:67–72. [PubMed]
  • Shi L, Fatemi SH, Sidwell RW, Patterson PH. A mouse model of mental illness: maternal influenza infection causes behavioral and pharmacological abnormalities in the offspring. J Neurosci. 2003;23:297–302. [PubMed]
  • So HC, Chen RY, Chen EY, Cheung EF, Li T, Sham PC. An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:77–85. [PubMed]
  • Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla KR, Giedd JN, Munson J, Dawson G, Dager SR. Brain structural abnormalities in young children with autism spectrum disorder. Neurology. 2002;59:184–192. [PubMed]
  • Steffek AE, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res. 2008;103:71–82. [PubMed]
  • Sultana R, Yu CE, Yu J, Munson J, Chen D, Hua W, Estes A, Cortes F, de la Barra F, Yu D, Haider ST, Trask BJ, Green ED, Raskind WH, Disteche CM, Wijsman E, Dawson G, Storm DR, Schellenberg GD, Villacres EC. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics. 2002;80:129–34. [PubMed]
  • Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gorman JD. Schizophrenia after prenatal famine. Arch Gen Psych. 1997;53:25–31. [PubMed]
  • Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805. [PubMed]
  • Verkman AS, Binder DK, Bloch O, Auguste K, Papadopoulos MC. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochim Biophys Acta. 2006;1758:1085–1093. [PubMed]
  • Weiss AP, Dewitt I, Goff D, Ditman T, Heckers S. Anterior and posterior hippocampal volumes in schizophrenia. Schizophr Res. 2005;73:103–112. [PubMed]
  • Wu Z, Irizarry R, Gentleman R, Murillo F, Spencer F. Technical report. Johns Hopkins University, Department of Biostatistics Working Papers; Baltimore, MD: 2004. A model based background adjustment for oligonucleotide expression arrays.
  • Zapala MA, Hovatta I, Ellison JA, Wodicka L, Del Rio JA, Tennant R, Tynan W, Brodie RS, Helton R, Stoveken BS, Winrow C, Lockhart DJ, Reilly JF, Young WG, Bloom FE, Lockhart DJ, Barlow C. Adult mouse brain gene expression patterns bear an embryologic imprint. Proc Natl Acad Sci USA. 2005;102:10357–10362. [PubMed]